Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | -.--% | -.--% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,000 | 0 | 0 | 18.04 % |
Stock B | 1 | 434,514,578 | 78,406,578 ( 18.04 %) | 0 |
Company contact information
Nunzia Pharmaceutical Corp.
1627 West 14th Street
90813, Long Beach
+714 609 9117
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.3M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- NUNZ Stock
- Company Nunzia Pharmaceutical Company